Chang-Hyun Kim

Prof. Dr. Chang-Hyun Kim


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
SJS.H. Jang
S.H. Jang
SSSung-Il Sohn
Sung-Il Sohn
HPHyungjong Park
Hyungjong Park
SLSeong-Joon Lee
Seong-Joon Lee
YKYong-Won Kim
Yong-Won Kim
JHJeong-Ho Hong
Jeong-Ho Hong
The safety and efficacy of tirofiban during endovascular therapy in patients undergoing intravenous thrombolysis with recombinant IV tPA remain unclear. This study aimed to investigate the safety and efficacy of intra-arterial tirofiban use during endovascular therapy in patients treated with IV tPA. Using a multicenter registry, we enrolled patients with acute ischemic stroke who underwent endovascular therapy. Safety outcomes included postprocedural parenchymal hematoma type 2 and/or thick subarachnoid hemorrhage, intraventricular hemorrhage, and 3-month mortality. Efficacy outcomes included the successful reperfusion rate, postprocedural reocclusion, and good outcomes at 3 months (mRS scores of 0-2). The tirofiban effect on the outcomes was evaluated using a multivariable analysis while adjusting for potential confounders. Among enrolled patients, we identified 314 patients with stroke (279 and 35 patients in the no tirofiban and tirofiban groups, respectively) due to an intracranial artery occlusion who underwent endovascular therapy with intravenous thrombolysis. A multivariable analysis revealed no association of intra-arterial tirofiban with postprocedural parenchymal hematoma type and/or thick subarachnoid hemorrhage (adjusted OR, 1.07; 95% CI, 0.20-4.10; P = .918), intraventricular hemorrhage (adjusted OR, 0.43; 95% CI, 0.02-2.85; P = .467), and 3-month mortality (adjusted OR, 0.38; 95% CI, 0.04-1.87; P = .299). Intra-arterial tirofiban was not associated with good outcome (adjusted OR, 2.22; 95% CI, 0.89 -6.12; P = .099). Using intra-arterial tirofiban during endovascular therapy after IV tPA could be safe.

21 January 2019 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
SLSeong-Joon Lee
Seong-Joon Lee
JHJi Man Hong
Ji Man Hong
JCJin Wook Choi
Jin Wook Choi
DKDong-Hun Kang
Dong-Hun Kang
YKYong-Won Kim
Yong-Won Kim
JLJin Soo Lee
Jin Soo Lee
Background: Differentiation of embolic and atherosclerotic occlusions is difficult prior to endovascular treatment (EVT) of acute ischemic stroke due to intracranial large artery occlusions. CTA-determined occlusion type has been reported to be associated with a negative cardiac embolic source and stent retriever failure, a potential of intracranial atherosclerosis (ICAS)-related occlusions. In this study, we evaluated the agreement between preprocedural identification of CTA-determined truncal-type occlusion (TTO) and postprocedural evaluation of underlying fixed focal stenosis (FFS) in the occlusion site. Methods: Patients who underwent intracranial EVT for acute ischemic stroke within 24 h of onset and who had baseline CTA were identified from a multicenter registry collected between January 2011 and May 2016. Preprocedural occlusion type was classified as TTO (target artery bifurcation saved) or branching-site occlusion (bifurcation involved) on CTA. As for postprocedural identification, FFS was evaluated by stepwise analyses of procedural and postprocedural angiographies. The agreement between TTO and FFS was evaluated in respective intracranial vascular beds. Receiver operating characteristics analyses were also performed. Results: A total of 509 patients were included [intracranial internal carotid artery (ICA): 193, middle cerebral artery (MCA) M1: 256, and vertebrobasilar artery (VBA): 60]. In preprocedural identification, 33 (17.1%), 41 (16.0%), and 29 patients (48.3%) had TTOs, respectively. TTOs had good agreement with angiographic FFS in M1 (positive predictive value: 63.4%, negative predictive value: 83.2%, likelihood ratio: 5.42, Pmultivariate < 0.001) and VBA (72.4%, 96.8%, and 4.54, respectively, Pmultivariate = 0.004), but not in intracranial ICA occlusions (Pmultivariate = 0.358). The area under the receiver operating characteristics curve was the largest for VBA (0.872, p < 0.001), followed by MCA M1 (0.671, p < 0.001), and intracranial ICA (0.551, p = 0.465). Conclusions: Agreement between preprocedural TTO and postprocedural FFS, both of which are surrogate markers for ICAS-related occlusions, is highest for VBA, followed by MCA M1 occlusions. There is no significant association in intracranial ICA.

3 June 2024 in Electronics
Verified
Journal Article
Open access
PDF file
MKMavlonbek Khomidov
Mavlonbek Khomidov
DLDeokwoo Lee
Deokwoo Lee
CKChang-Hyun Kim
Chang-Hyun Kim
Jong-Ha LeeJong-Ha Lee
Jong-Ha Lee
Early detection and prevention of stress is crucial because stress affects our vital signs like heart rate, blood pressure, skin temperature, respiratory rate, and heart rate variability. There are different ways to determine stress using different devices, such as the electrocardiogram (ECG), electrodermal activity (EDA), the electroencephalogram (EEG), photoplethysmography (PPG), or a questionnaire-based method of stress assessment. In this study, we proposed a camera-based real-time stress detection system using remote photoplethysmography (rPPG). We trained different machine learning models using three datasets: the SWELL dataset, the PPG sensor dataset, and the last ECG and EEG-based stress dataset. The models with the highest predictive accuracy were used to classify stress based on HR and HRV features obtained from the face using a camera. HR and HRV estimations from the face were validated on the PURE public dataset and the custom dataset. In this study, it was observed that the random forest algorithm performs significantly better than other models, achieving an impressive 99% predictive accuracy in the SWELL dataset. In the second dataset, the logistic regression technique shows the best result, achieving an accuracy rate of 84.24%. In the last dataset, the ensemble model achieved an accuracy rate of 67%. We also checked the proposed algorithm in the process of public speaking to estimate stress in a real-time situation.

1 July 2019 in World Neurosurgery
Verified
Journal Article
Closed access
JPJaechan Park
Jaechan Park
YKYoungseok Kwak
Youngseok Kwak
CKChang-Hyun Kim
Chang-Hyun Kim
YLYoungseop Lee
Youngseop Lee
YCYeon-Ju Choi
Yeon-Ju Choi
BOBoram Ohk
Boram Ohk

1 January 2023 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JBJang-Hyun Baek
Jang-Hyun Baek
BKByung Moon Kim
Byung Moon Kim
SSSang Hyun Suh
Sang Hyun Suh
HJHong-Jun Jeon
Hong-Jun Jeon
EIEun Hyun Ihm
Eun Hyun Ihm
YKYoung Dae Kim
Young Dae Kim
Baek JH, et al. Korean J Radiol. 2023 Feb;24(2):145-154. https://doi.org/10.3348/kjr.2022.0618

3 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
TJTaemi Jung
Taemi Jung
Jong-Ha LeeJong-Ha Lee
Jong-Ha Lee
JHJin-Chul Heo
Jin-Chul Heo
CKChang-Hyun Kim
Chang-Hyun Kim
Background/Objectives: Neuroinflammation is associated with the progression of various brain diseases, and the management of neuroinflammation-induced neural damage is a crucial aspect of treating neurological disorders. This study investigated the anti-inflammatory efficacy of photobiomodulation therapy (PBMT) using 660 nm phototherapy in a rat model with lipopolysaccharide (LPS)-induced neuroinflammation. Methods: We induced inflammation in rat brains via intraperitoneal injection of LPS and subjected the treatment group to 660 nm phototherapy to examine its protective effect against hippocampal damage based on pathological, histological, and immunohistochemical tissue analyses. Results: The 660 nm treated rats showed a significant decrease in hippocampal structural damage and cell death compared to the LPS-treated group. We observed reduced expression of the inflammation markers GFAP, TNF-α, and IL-1β in the hippocampus of the treatment group, and an increase in SIRT1 expression across all hippocampal regions. Conclusions: This study presents a promising method for controlling neuroinflammation and providing neuroprotection and inflammation relief. PBMT represents a non-invasive therapeutic approach with minimal side effects ensured through the proper control of light irradiation.